US Stock MarketDetailed Quotes

OPRX OptimizeRx

Watchlist
  • 4.910
  • +0.160+3.37%
Close Dec 20 16:00 ET
  • 4.910
  • 0.0000.00%
Post 16:07 ET
90.45MMarket Cap-3.66P/E (TTM)

OptimizeRx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OptimizeRx Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
25.00M
21.31M
-3.69M
Miss Est.
+53.06%
+30.48%
-14.75%
EPS
-0.19
-0.50
-0.31
Miss Est.
-10.30%
-194.12%
-166.81%
Analyst Rating
Strong Buy

Dec 21, 2024

OptimizeRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.260M--
--2024/Q4-- / 29.696M--
Nov 13, 20242024/Q321.309M / 24.997M--
Aug 8, 20242024/Q218.812M / 20.463M--
May 14, 20242024/Q119.690M / 18.132M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.260M--
--2024/Q4-- / 29.696M--
Nov 13, 20242024/Q321.309M / 24.997M--
Aug 8, 20242024/Q218.812M / 20.463M--
May 14, 20242024/Q119.690M / 18.132M--

Unlock Free Earnings Estimates

OptimizeRx Earnings Reports

  • OptimizeRx | 10-Q: Q3 2024 Earnings Report

    Nov 14 15:37 ET

  • OptimizeRx | 8-K: OptimizeRx Reports Third Quarter 2024 Financial Results

    Nov 13 16:17 ET

  • OptimizeRx | 10-Q: Q2 2024 Earnings Report

    Aug 15 16:34 ET

  • OptimizeRx | 8-K: OptimizeRx Reports Second Quarter 2024 Financial Results

    Aug 8 16:31 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data